Pinnacle Associates LTD Bicycle Therapeutics PLC Transaction History
Pinnacle Associates LTD
- $6.59 Billion
- Q2 2025
A detailed history of Pinnacle Associates LTD transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Pinnacle Associates LTD holds 171,953 shares of BCYC stock, worth $1.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
171,953
Previous 214,278
19.75%
Holding current value
$1.2 Million
Previous $1.82 Million
34.3%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding BCYC
# of Institutions
118Shares Held
42.2MCall Options Held
111KPut Options Held
16.6K-
Baker Bros. Advisors LP New York, NY10.9MShares$76.2 Million0.77% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$24.2 Million6.5% of portfolio
-
Armistice Capital, LLC New York, NY2.8MShares$19.6 Million0.34% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$18.6 Million0.12% of portfolio
-
Siren, L.L.C. New York, NY2.01MShares$14.1 Million0.72% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $208M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...